Q4 2023
Released Feb 27, 2024, after the close
10-K filed Feb 27, 2024, 58 days after period end · 0001628280-24-007235
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$65.83M$65.83M derived+6.1% vs Q4 2022−4.9% vs Q3 2023
Net Income-$95.43M-$95.43M derivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$123,980,000N/M
Operating Cash Flowderived-$14,917,000N/M
Free Cash Flowderived-$15,139,000N/M
Margins · derived
Operating margin-188.3%−31.5 pt vs Q4 2022
Net margin-145.0%−45.4 pt vs Q4 2022
What the release said
The release
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $65.83M | $62.04M | $43.96M | $15.09M |
| Net Income | -$95.43M | -$61.77M | -$211.83M | -$76.55M |
| EPS Diluted | — | — | -$2.22 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR